ArticleNature reviews. Clinical oncology2023
Early MRD predicts disease recurrence and benefit from adjuvant chemotherapy in CRC.
Article in Nature reviews. Clinical oncology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed, 15 citations in OpenAlex.
- MRDadaptis: self-adaptive parameter configuration enhances minimal residual disease detection in heterogeneous ctDNA samples.Briefings in bioinformatics · 2025Article
- Antitumor Activity ofMarine drugs · 2025Article
- Multimodal cell-free DNA whole-genome TAPS is sensitive and reveals specific cancer signals.Nature communications · 2025Article
- Evaluation of Anticancer and Immunomodulatory Effects of Microwave-Extracted Polysaccharide fromFoods (Basel, Switzerland) · 2024Article
- Spatial effects of infiltrating T cells on neighbouring cancer cells and prognosis in stage III CRC patients.The Journal of pathology · 2024Article
- Article
- STING-targeted PET imaging: unveiling tumor immunogenicity post-chemotherapy in colorectal cancer.European journal of nuclear medicine and molecular imaging · 2024Article
- Spatial Effects of Infiltrating T cells on Neighbouring Cancer Cells and Prognosis in Stage III CRC patients.bioRxiv : the preprint server for biology · 2024Article
- A competing risk nomogram to predict cancer-specific mortality of patients with late-onset colorectal cancer.Journal of cancer research and clinical oncology · 2023Article
Corrections and comments
- Comment on
Authors and funding
1 author at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.